Outcomes/instruments | T0 week 0 | T1a (pre-treatment) Week 6 | T1b (post-treatment) Week 6 | T2a (pre-treatment) Week 12 | T2b (post-treatment) Week 12 |
---|---|---|---|---|---|
Primary outcome | Â | Â | Â | Â | Â |
Well-being (DS-DAT) | X | X | X | X | X |
Secondary outcomes | Â | Â | Â | Â | Â |
Pain (PAIC-15) | X | X | X | X | X |
Quality of life (QUALID) | X | Â | X | Â | X |
Neuropsychiatric symptoms (NPI-NH) | X | Â | X | Â | X |
Agitation (CMAI) | X | Â | X | Â | X |
Depressive symptoms (CSDD) | X | Â | X | Â | X |
Stages of dementia (GDS) | X | Â | Â | Â | Â |
Rest/activity (Actigraphy) | X | Â | Â | Â | X |
Medication use (ATC classification) | X | Â | Â | Â | X |